Panbela Therapeutics Inc (PBLA)
0.3813
-0.03
(-7.00%)
USD |
OTCM |
May 02, 16:00
Panbela Therapeutics Market Cap: 1.851M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.851M |
| May 01, 2024 | 1.990M |
| April 30, 2024 | 2.088M |
| April 29, 2024 | 2.113M |
| April 26, 2024 | 1.990M |
| April 25, 2024 | 2.136M |
| April 24, 2024 | 1.991M |
| April 23, 2024 | 2.039M |
| April 22, 2024 | 2.305M |
| April 19, 2024 | 2.039M |
| April 18, 2024 | 2.376M |
| April 17, 2024 | 2.505M |
| April 16, 2024 | 2.549M |
| April 15, 2024 | 2.622M |
| April 12, 2024 | 2.864M |
| April 11, 2024 | 2.816M |
| April 10, 2024 | 2.476M |
| April 09, 2024 | 2.670M |
| April 08, 2024 | 2.620M |
| April 05, 2024 | 2.649M |
| April 04, 2024 | 2.782M |
| April 03, 2024 | 2.787M |
| April 02, 2024 | 2.670M |
| April 01, 2024 | 2.670M |
| March 28, 2024 | 3.253M |
| Date | Value |
|---|---|
| March 27, 2024 | 3.276M |
| March 26, 2024 | 3.107M |
| March 25, 2024 | 3.107M |
| March 22, 2024 | 3.059M |
| March 21, 2024 | 2.336M |
| March 20, 2024 | 2.328M |
| March 19, 2024 | 2.193M |
| March 18, 2024 | 2.167M |
| March 15, 2024 | 2.089M |
| March 14, 2024 | 2.089M |
| March 13, 2024 | 2.263M |
| March 12, 2024 | 2.332M |
| March 11, 2024 | 2.611M |
| March 08, 2024 | 1.932M |
| March 07, 2024 | 2.402M |
| March 06, 2024 | 3.864M |
| March 05, 2024 | 4.282M |
| March 04, 2024 | 4.247M |
| March 01, 2024 | 4.421M |
| February 29, 2024 | 4.108M |
| February 28, 2024 | 4.143M |
| February 27, 2024 | 4.282M |
| February 26, 2024 | 4.004M |
| February 23, 2024 | 3.899M |
| February 22, 2024 | 3.864M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.6435M
Minimum
Jan 30 2024
78.72M
Maximum
Feb 09 2021
23.31M
Average
25.63M
Median
Dec 20 2021
Market Cap Benchmarks
| Processa Pharmaceuticals Inc | 6.512M |
| Fate Therapeutics Inc | 405.88M |
| Ardelyx Inc | 1.580B |
| Checkpoint Therapeutics Inc | 52.82M |
| Palisade Bio Inc | 6.194M |
Market Cap Related Metrics
| PS Ratio | 0.0584 |
| Price | 0.3813 |
| Earnings Yield | -161.6K% |